# Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant

> **NCT04177004** · PHASE1 · SUSPENDED · sponsor: **City of Hope Medical Center** · enrollment: 53 (estimated)

## Conditions studied

- Allogeneic Hematopoietic Stem Cell Transplant Recipient
- Hematopoietic and Lymphoid Cell Neoplasm

## Interventions

- **PROCEDURE:** Allogeneic Hematopoietic Stem Cell Transplantation
- **DRUG:** Cyclophosphamide
- **DRUG:** Etoposide
- **RADIATION:** Fractionated Stereotactic Radiation Therapy
- **DRUG:** Goat Milk
- **BIOLOGICAL:** Palifermin
- **DRUG:** Sirolimus
- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT04177004
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2021-04-30
- **Primary completion:** 2026-10-27
- **Final completion:** 2026-10-27
- **Target enrollment:** 53 (ESTIMATED)
- **Why stopped:** Accrual goal met
- **Last updated:** 2026-04-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04177004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04177004, "Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04177004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*